Yıl: 2018 Cilt: 46 Sayı: 4 Sayfa Aralığı: 283 - 295 Metin Dili: İngilizce DOI: 10.5543/tkda.2018.49579 İndeks Tarihi: 04-08-2020

The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study

Öz:
Objective: The aim of this study was to determine the baseline clinical characteristics and the cardiovascular drug usage of patients aged ≥80 years who were admitted to cardiology clinics and to compare the cardiovascular diseaseand risk factors with patients aged 65-79 years who participated in the Epidemiology of Cardiovascular Disease inElderly Turkish Population (ELDER-TURK) study.Methods: The ELDER-TURK study included 5694 patientsaged over 65 years who were followed up at cardiology clinics between March 2015 and December 2015. The prevalence of cardiovascular diseases and the risk factors of 1098patients aged ≥80 years (Group II) were compared with 4596patients aged 65–79 years (Group I).Results: The mean age of Group I was 71.1±4.31 years(male: 50.2%) and the mean age of Group II was 83.5±3.12years (male: 47.5%). The prevalence rate was 71.3% forhypertension, 24.6% for diabetes mellitus (DM), 44.7% forcoronary artery disease (CAD), 35.9% for atrial fibrillation(AF), and 15.5% for renal failure. A statistical difference inthe prevalence of comorbid conditions and cardiovasculardisease risk factors, such as DM, CAD, renal failure, andAF was seen in the very elderly group (p<0.001, p=0.002,p<0.001, p<0.001, respectively). In all, 28.7% of the very elderly were using a beta-blocker, 10.1% an angiotensin system inhibitor, 28.4% an angiotensin receptor blocker, and32.7% a mineralocorticoid receptor antagonist.Conclusion: Valuable data about the prevalence of cardiovascular and comorbid diseases and medication usageamong Turkey`s very elderly patients who were admitted tocardiology clinics was gathered and analyzed.
Anahtar Kelime:

Kardiyoloji kliniklerine başvuran çok ileri yaş Türk hastalarının kardiyovasküler hastalık prevelansı, risk faktörleri ve kardiyovasküler ilaç kullanımları: ELDER-TURK çalışmasının bir altgrup analizi

Öz:
Amaç: Bu çalışmanın amacı, kardiyoloji kliniklerine başvuran 80 yaş üstü hastaların kardiyovasküler ilaç kullanımı ve temel klinik özelliklerini belirlemek ve ELDER-TURK (Epidemiology of Cardiovascular Disease in Elderly Turkish Population) çalışmasına katılan 65-79 yaş arası hastaların risk faktörleri ve kardiyovasküler hastalıklarını karşılaştırmaktır. Yöntemler: ELDER-TURK çalışmasına Mart 2015 ve Aralık 2015 tarihleri arasında kardiyoloji kliniklerine takip olan 65 yaş üstü 5694 hasta alındı. Kardiyoloji kliniklerinde takip edilen 80 yaş ve üstü olan 1098 hastanın (Grup II) kardiyovasküler hastalık prevalansı ve risk faktörü 65–79 yaş arasındaki 4596 hasta grubu (Grup I) ile karşılaştırıldı. Bulgular: Grup I’in ortalama yaşı 71.1±4.31 (%50.2 erkek), Grup II’nin ortalama yaşı 83.5±3.12 idi (%47.5 erkek). Hipertansiyon prevelansı %71.3, diabetes mellitus prevelansı %24.6, koroner arter hastalığı prevelansı %44.7, atriyal fibrillasyon prevelansı %35.9 ve böbrek yetersizliği prevelansı %15.5 olarak saptandı. Çok ileri yaş hasta grubunda diabetes mellitus, koroner arter hastalığı, böbrek yetersizliği ve atriyal fibrilasyon gibi kardiyovasküler hastalık risk faktörleri ve komorbid hastalık prevelansında istatistiksel farklılıklar saptandı (sırasıyla, p<0.001, p=0.002, p <0.001, p<0.001). İleri yaş hastaların %28.7’si beta bloker, %10.1’i anjiotensin inhibitorü, %28.4’ü anjiotensin reseptör blokeri, %32.7 mineralokortikoid reseptör antagonisti kullanmaktaydı. Sonuç: Kardiyoloji kliniklerinde takipli çok ileri yaş Türk hastaları ile ilgili, kardiyovasküler hastalık prevelansı, komorbid hastalıklar ve ilaç kullanımları açısından değerli bir veri tabanı toplandı ve incelendi.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Turkish Statistical Institute. National Health Report of 2014. Turkey in Statistics 2014. Publication No: 4380. Ankara; 2014. Available at: http://www.turkstat.gov.tr/. Accessed Sep 2, 2016.
  • 2. European Commission. Eurostat Death Statistics Report of 2011. Eurostat regional yearbook 2011. Luxemburg: Publications Office of the European Union; 2011. Available at: http:// ec.europa.eu/eurostat/. Accessed Sep 2, 2016.
  • 3. Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med 2009;25:563–77. [CrossRef]
  • 4. Zoghi M, Özyüncü N, Özal E, Çakmak HA, Yayla Ç, İçli A, et al. Frequency of Cardiovascular Diseases and Drug Use in Turkish Elderly Population Followed Up at Cardiology Clinics: The Elderturk Study. Turkish Journal of Geriatrics 2017;20:73–81.
  • 5. European Communities. European Regional Statistics - Reference Guide. Luxemburg: Office for Official Publications of the European Communities; 2004. Available at: http://ec.europa.eu/eurostat/documents/3859598/5875497/KS-BD-04- 001-EN.PDF/94004564-faff-4d93-90dd-2bec2c18313a?version=1.0. Accessed May 18, 2018.
  • 6. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. 2nd ed. Geneva: WHO; 1982. p. 124–7.
  • 7. Macfarlane PW. Minnesota coding and the prevalence of ECG abnormalities. Heart 2000;84:582–4. [CrossRef]
  • 8. O’Brien E, Pettrie J, Littler W, de Swiet M, Padfield PL, Altman, DG, et al. The British Hypertension kociety protocol for the evaluation of blood preskure measuring devices. J Hypertens 1993:11;S43–62.
  • 9. Prevention of diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;844:1–100.
  • 10. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al; National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003;111:1416–21. [CrossRef]
  • 11. Fleg JL, Forman DE, Berra K, Bittner V, Blumenthal JA, Chen MA, et al; American Heart Association Committees on Older Populations and Exercise Cardiac Rehabilitation and Prevention of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic He. Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation 2013;128:2422–46. [CrossRef]
  • 12. Williams MA, Fleg JL, Ades PA, Chaitman BR, Miller NH, Mohiuddin SM, et al; American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or =75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002;105:1735–43. [CrossRef]
  • 13. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al; World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458–73. [CrossRef]
  • 14. Jackson CF, Wenger NK. Cardiovascular disease in the elderly. Rev Esp Cardiol 2011;64:697–712. [CrossRef]
  • 15. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016;133:e38–360. [CrossRef]
  • 16. Onat A, Can G. Erişkinlerimizde Kalp Hastalıkları Prevalansı, Yeni Koroner Olaylar ve Kalpten Ölüm Sıklığı. In: Onat A, editor. TEKHARF 2017 Tıp Dünyasının Kronik Hastalıklara Yaklaşımına Öncülük. Istanbul: Logos Yayıncılık; 2017. p. 23.
  • 17. Altun B, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, et al; Turkish Society of Hypertension and Renal Diseases. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 2005;23:1817–23. [CrossRef]
  • 18. Vaes B, Pasquet A, Wallemacq P, Rezzoug N, Mekouar H, Olivier PA, et al. The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr 2010;10:39. [CrossRef]
  • 19. Özkara A, Turgut F, Kanbay M, Selocoki Y, Akcay A. Population-based cardiovascular risk factors in the elderly in Turkey: A cross-sectional survey. Cent Eur J Med 2008:3;173–8.
  • 20. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention &Rehabilitation (EACPR). Atherosclerosis 2016;252:207–74.
  • 21. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011;123:2434–506.
  • 22. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 2002;7:29–49. [CrossRef]
  • 23. Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007;167:921–7.
  • 24. Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S, et al.Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551–6. [CrossRef]
  • 25. Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067–78.
  • 26. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370–5. [CrossRef]
  • 27. Shastri S, Tighiouart H, Katz R, Rifkin DE, Fried LF, Shlipak MG, et al. Chronic kidney disease in octogenarians. Clin J Am Soc Nephrol 2011;6:1410–7. [CrossRef]
  • 28. Tangiisuran B, Davies JG, Wright JE, Rajkumar C. Adverse drug reactions in a population of hospitalized very elderly patients. Drugs Aging 2012;29:669–79. [CrossRef]
APA gok g, Sinan U, ÖZYÜNCÜ N, ZOGHİ M (2018). The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. , 283 - 295. 10.5543/tkda.2018.49579
Chicago gok gulay,Sinan Umit Yasar,ÖZYÜNCÜ Nil,ZOGHİ Mehdi The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. (2018): 283 - 295. 10.5543/tkda.2018.49579
MLA gok gulay,Sinan Umit Yasar,ÖZYÜNCÜ Nil,ZOGHİ Mehdi The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. , 2018, ss.283 - 295. 10.5543/tkda.2018.49579
AMA gok g,Sinan U,ÖZYÜNCÜ N,ZOGHİ M The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. . 2018; 283 - 295. 10.5543/tkda.2018.49579
Vancouver gok g,Sinan U,ÖZYÜNCÜ N,ZOGHİ M The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. . 2018; 283 - 295. 10.5543/tkda.2018.49579
IEEE gok g,Sinan U,ÖZYÜNCÜ N,ZOGHİ M "The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study." , ss.283 - 295, 2018. 10.5543/tkda.2018.49579
ISNAD gok, gulay vd. "The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study". (2018), 283-295. https://doi.org/10.5543/tkda.2018.49579
APA gok g, Sinan U, ÖZYÜNCÜ N, ZOGHİ M (2018). The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. Türk Kardiyoloji Derneği Arşivi, 46(4), 283 - 295. 10.5543/tkda.2018.49579
Chicago gok gulay,Sinan Umit Yasar,ÖZYÜNCÜ Nil,ZOGHİ Mehdi The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. Türk Kardiyoloji Derneği Arşivi 46, no.4 (2018): 283 - 295. 10.5543/tkda.2018.49579
MLA gok gulay,Sinan Umit Yasar,ÖZYÜNCÜ Nil,ZOGHİ Mehdi The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. Türk Kardiyoloji Derneği Arşivi, vol.46, no.4, 2018, ss.283 - 295. 10.5543/tkda.2018.49579
AMA gok g,Sinan U,ÖZYÜNCÜ N,ZOGHİ M The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. Türk Kardiyoloji Derneği Arşivi. 2018; 46(4): 283 - 295. 10.5543/tkda.2018.49579
Vancouver gok g,Sinan U,ÖZYÜNCÜ N,ZOGHİ M The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study. Türk Kardiyoloji Derneği Arşivi. 2018; 46(4): 283 - 295. 10.5543/tkda.2018.49579
IEEE gok g,Sinan U,ÖZYÜNCÜ N,ZOGHİ M "The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study." Türk Kardiyoloji Derneği Arşivi, 46, ss.283 - 295, 2018. 10.5543/tkda.2018.49579
ISNAD gok, gulay vd. "The prevalence of cardiovascular diseases, risk factors, and cardiovascular drug therapy in very elderly Turkish patients admitted to cardiology clinics: A subgroup analysis of the ELDER-TURK study". Türk Kardiyoloji Derneği Arşivi 46/4 (2018), 283-295. https://doi.org/10.5543/tkda.2018.49579